Antonio Costa

Chief Executive Officer at Diant Pharma, Inc.

Health Technology

Profile

Antonio Costa is associated with Diant Pharma, Inc. as the Chief Executive Officer since 2019.
He is also the founder of Diant Pharma, Inc. which was founded in 2019.

Antonio Costa active positions

Companies	Position	Start
Diant Pharma, Inc. Diant Pharma, Inc. BiotechnologyHealth Technology Diant Pharma, Inc. is a company that specializes in nanoparticle formulation and offers services related to cGMP design, process analytical technology (PAT) integration, and other nanoparticle-related services. The company is based in Manchester, CT. The company's benchtop LARU is a laboratory nanoparticle synthesis system suitable for R&D, academic work, and training operations. DIANT® Pharma was formed in 2019 and emerged from years of rigorous research at the University of Connecticut, resulting in differentiated, innovative continuous processing technologies for nanoparticle-based therapeutics and vaccines. The company was founded in 2019 by Diane Burgess, Antonio Costa. Antonio Costa has been the CEO since 2019.	Chief Executive Officer	2018-12-31

All active positions of Antonio Costa

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Antonio Costa's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Diant Pharma, Inc. Diant Pharma, Inc. BiotechnologyHealth Technology Diant Pharma, Inc. is a company that specializes in nanoparticle formulation and offers services related to cGMP design, process analytical technology (PAT) integration, and other nanoparticle-related services. The company is based in Manchester, CT. The company's benchtop LARU is a laboratory nanoparticle synthesis system suitable for R&D, academic work, and training operations. DIANT® Pharma was formed in 2019 and emerged from years of rigorous research at the University of Connecticut, resulting in differentiated, innovative continuous processing technologies for nanoparticle-based therapeutics and vaccines. The company was founded in 2019 by Diane Burgess, Antonio Costa. Antonio Costa has been the CEO since 2019.	Health Technology